Reldesemtiv Aids Motor and Respiratory Strength in Types 2 and 3, Early Trial Finds

SMA News Today’s multimedia associate, Price Wooldridge, discusses how the therapy, Reldesemtiv, aids motor and respiratory strength in Spinal Muscular Atrophy (SMA) Types 2 and 3.

Also, with vaccinations ramping up across the country daydreaming is a popular trend on the forums. Post vaccination activities top the list. Recent articles by SMA News Today columnists are always of interest as well.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/